Asymchem Laboratories (Tianjin) Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

2,033.25

2,238.05

1,575.21

1,777.18

1,647.83

1,799.91

1,570.13

Other Operating Income

0.00

Total Operating income

2,033.25

2,238.05

1,575.21

1,777.18

1,647.83

1,799.91

1,570.13

Raw Material Cost

1,158.63

1,359.71

981.81

1,021.51

979.66

1,131.67

881.55

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

3.35

3.69

3.42

3.66

3.07

6.29

1.27

Selling and Distribution Expenses

295.33

274.92

259.70

271.69

209.48

361.08

243.63

Other Expenses

13.99

16.58

15.13

15.05

13.90

12.81

16.13

Total Expenditure (Excl Depreciation)

1,597.25

1,804.07

1,396.24

1,447.35

1,331.19

1,627.13

1,287.71

Operating Profit (PBDIT) excl Other Income

436

434

179

329.79999999999995

316.6

172.8

282.4

Other Income

-30.36

13.43

60.72

64.64

79.53

206.81

-5.28

Operating Profit (PBDIT)

376.55

535.66

391.00

521.58

519.11

420.46

403.80

Interest

3.35

3.69

3.42

3.66

3.07

6.29

1.27

Exceptional Items

0.76

10.32

1.10

1.38

10.98

34.94

-4.35

Gross Profit (PBDT)

874.63

878.34

593.40

755.67

668.17

668.24

688.58

Depreciation

0.00

166.38

165.74

146.43

145.10

146.97

147.88

Profit Before Tax

373.96

375.90

222.93

372.88

381.92

302.14

250.31

Tax

36.35

46.37

33.35

58.55

34.94

83.97

20.39

Provisions and contingencies

0.00

Profit After Tax

343.40

364.53

199.72

313.84

349.20

258.06

229.81

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

343.40

364.53

199.72

313.84

349.20

258.06

229.81

Share in Profit of Associates

0.00

Minority Interest

-3.57

2.02

-3.77

-2.46

-2.18

-3.30

-3.73

Other related items

0.00

Consolidated Net Profit

339.83

366.55

195.95

311.37

347.02

254.76

226.08

Equity Capital

0.00

Face Value

1.13

1.11

1.09

1.1

1.07

1.06

1.11

Reserves

20,374.71

19,642.22

18,963.75

18,714.93

18,432.28

17,927.06

18,392.07

Earnings per share (EPS)

0.95

1.01

0.56

0.88

0.96

0.73

0.65

Diluted Earnings per share

0.95

1.01

0.56

0.88

0.96

0.73

0.65

Operating Profit Margin (Excl OI)

20.01%

15.9%

10.45%

17.47%

17.87%

3.7%

16.64%

Gross Profit Margin

18.39%

24.23%

24.67%

29.22%

31.98%

24.95%

25.36%

PAT Margin

16.89%

16.29%

12.68%

17.66%

21.19%

14.34%

14.64%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 23.39% vs 8.20% in Mar 2025

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -2.07% vs 14.11% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -7.44% vs 30.25% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 6.45% vs 416.67% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Asymchem Laboratories (Tianjin) Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(HKD)

Change(%)

Net Sales

2,033.25

Other Operating Income

0.00

Total Operating income

2,033.25

Raw Material Cost

1,158.63

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

3.35

Selling and Distribution Expenses

295.33

Other Expenses

13.99

0.00

13.99

Total Expenditure (Excl Depreciation)

1,597.25

Operating Profit (PBDIT) excl Other Income

436.01

0.00

436.01

Other Income

-30.36

Operating Profit (PBDIT)

376.55

Interest

3.35

Exceptional Items

0.76

Gross Profit (PBDT)

874.63

Depreciation

0.00

Profit Before Tax

373.96

Tax

36.35

Provisions and contingencies

0.00

Profit After Tax

343.40

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

343.40

Share in Profit of Associates

0.00

Minority Interest

-3.57

Other related items

0.00

Consolidated Net Profit

339.83

Equity Capital

0.00

Face Value

1.13

0.00

Reserves

20,374.71

Earnings per share (EPS)

0.95

Diluted Earnings per share

0.95

Operating Profit Margin (Excl OI)

20.01%

0.00

20.01%

Gross Profit Margin

18.39%

0.00

18.39%

PAT Margin

16.89%

0.00

16.89%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 203.33 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -9.15% vs 42.08% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 23.39% vs 8.20% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 33.98 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -7.31% vs 87.04% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -2.07% vs 14.11% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 40.69 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -22.08% vs 58.10% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -7.44% vs 30.25% in Mar 2025

Quarterly - Interest

Interest 0.33 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -10.81% vs 8.82% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 6.45% vs 416.67% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.01%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025